Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 1

Jacob Donald Wudtke

(920) 370 3034 • wudtke.jacob@outlook.com

Objective
 Use a persistent work ethic and desire to achieve results to build a career as a medical dosimetrist
working amongst a motivated multi-disciplinary team focused on delivering the highest standard
of care while emphasizing patient safety.

Related Work Experience


 Medical Dosimetry Assistant • UW-Health: Madison, WI (June 2022 to Present)
 Radiation Therapist • UW-Health: Madison, WI (August 2021 to June 2022)
 Lead Radiation Therapist • Northwestern Medicine Proton Center: Warrenville, IL (December
2020 – August 2021)
 Radiation Therapist • Northwestern Medicine Proton Center: Warrenville, IL (July 2019 to
December 2020)
 Radiation Therapy Intern • Advocate Lutheran General Hospital: Park Ridge, IL (July 2018-
July 2019)
o Awarded Intern of the Year
 Certified Nursing Assistant • Benedictine Manor: La Crosse, WI (March 2016-June 2018)

Equipment and Procedural Experience


 Varian TrueBeam  Prone Breast Treatment Techniques
 Varian Clinac 21 ix  Stereotactic Body Radiation Therapy
 Proton Therapy Pencil Beam Scanning  Utilization of TLD’s/OSL’s
 Proton Therapy Uniform Scanning  Portal/KV Orthogonal Imaging
 MOSAIQ Record and Verify System  IV Contrast Administration
 GE Optima CT Simulator  Photon Grid Therapy
 TomoTherapy  AlignRT Surface Tracking
 4D CT Simulation  CRAD Surface Tracking
 Respiratory Gating Utilizing Deep
Inspiration Breath Hold

Education and Certifications


 Bachelor of Science in Radiation Therapy • University of Wisconsin – La Crosse
o 4-year collegiate student athlete – Football
 Michael Anderson Award Recipient
o Dean’s List 8 semesters
o Current member of Lambda Nu Radiologic Sciences Honor Society
 Fall 2018 Lambda Nu Scholarship Recipient
 ARRT Board Certified (2019)
 BLS CPR Certified (2021)

Professional Development and Research


 Radiation Therapists of Wisconsin - Student Member (2017-2019)
o Review of Literature – Comparison of Octreotide LAR and Lutathera® for Inoperable
Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (2019)
 AAMD - Member (2022-present)
 ARRT - Member (2017-present)
 ASRT - Member (2017-present)

You might also like